Works matching IS 13520504 AND DT 2017 AND VI 24 AND IP 6

Results: 11

Long-term safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 6, p. 514, doi. 10.1111/jvh.12670

By:

Han, G.‐R.;
Jiang, H.‐X.;
Wang, C.‐M.;
Ding, Y.;
Wang, G.‐J.;
Yue, X.;
Zhou, L.;
Zhao, W.

Publication type:

Article

Chronic hepatitis C and chronic kidney disease: Advances, limitations and unchartered territories.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 6, p. 442, doi. 10.1111/jvh.12681

By:

Mendizabal, M.;
Reddy, K. R.

Publication type:

Article

Impact of treatment on hepatitis C virus transmission and incidence in Egypt: A case for treatment as prevention.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 6, p. 486, doi. 10.1111/jvh.12671

By:

Ayoub, H. H.;
Abu‐Raddad, L. J.

Publication type:

Article

Cover Image.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 6, p. i, doi. 10.1111/jvh.12592

By:

Ayoub, H. H.;
Abu‐Raddad, L. J.

Publication type:

Article

Antibody-dependent and antibody-independent uptake of HBsAg across human leucocyte subsets is similar between individuals with chronic hepatitis B virus infection and healthy donors.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 6, p. 506, doi. 10.1111/jvh.12667

By:

Tharinger, H.;
Rebbapragada, I.;
Samuel, D.;
Novikov, N.;
Nguyen, M. H.;
Jordan, R.;
Frey, C. R.;
Pflanz, S.

Publication type:

Article

A systematic model improves hepatitis C virus birth cohort screening in hospital-based primary care.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 6, p. 477, doi. 10.1111/jvh.12669

By:

Goel, A.;
Sanchez, J.;
Paulino, L.;
Feuille, C.;
Arend, J.;
Shah, B.;
Dieterich, D.;
Perumalswami, P. V.

Publication type:

Article

Issue Information.

Published in:: Journal of Viral Hepatitis, 2017, v. 24, n. 6, p. 439, doi. 10.1111/jvh.12595
Publication type:: Article

Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 6, p. 472, doi. 10.1111/jvh.12665

By:

Toyoda, H.;
Tada, T.;
Takaguchi, K.;
Senoh, T.;
Shimada, N.;
Hiraoka, A.;
Michitaka, K.;
Ishikawa, T.;
Kumada, T.

Publication type:

Article

Hepatitis C infection and other drug-related harms among inpatients who injected drugs in Turkey.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 6, p. 496, doi. 10.1111/jvh.12662

By:

Alaei, A.;
Alaei, K.;
Waye, K.;
Tracy, M.;
Nalbandyan, M.;
Mutlu, E.;
Cetin, M. K.

Publication type:

Article

Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 6, p. 454, doi. 10.1111/jvh.12663

By:

Conti, F.;
Brillanti, S.;
Buonfiglioli, F.;
Vukotic, R.;
Morelli, M. C.;
Lalanne, C.;
Massari, M.;
Foschi, F. G.;
Bernabucci, V.;
Serio, I.;
Prati, G. M.;
Negri, E.;
Badia, L.;
Caraceni, P.;
Muratori, P.;
Vitale, G.;
Porro, A.;
Morotti, M.;
Mazzella, G.;
Andreone, P.

Publication type:

Article

Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus ( HCV) infection in patients with severe renal impairment: A multicentre experience.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 6, p. 464, doi. 10.1111/jvh.12664

By:

Muñoz‐Gómez, R.;
Rincón, D.;
Ahumada, A.;
Hernández, E.;
Devesa, M. J.;
Izquierdo, S.;
Ortiz, M.;
Hernández‐Albujar, A.;
Fernández‐Rodríguez, C.;
Calvo, M.;
González, R.;
Lozano, M.;
Castellano, G.;
Fernández‐Vázquez, I.

Publication type:

Article